| DXCM |
Report |
Q2 2026 revenue |
BEAT |
pred ~$1.310B vs. cons $1.290B |
MEDIUM |
| DXCM |
Report |
Q2 2026 adjusted EPS |
BEAT |
pred ~$0.64 vs. cons $0.61 |
MEDIUM |
| DXCM |
Report |
Q2 2026 non-GAAP gross margin |
BEAT |
pred ~64.2% vs. cons 63.5% |
LOW |
| DXCM |
Guide |
Revenue guidance |
BETTER |
guide ~$5.24B vs. cons $5.22B (FY2026) |
MEDIUM |
| DXCM |
Guide |
Non-GAAP gross-margin guidance |
BETTER |
guide ~64.0% vs. cons 63.5% (FY2026) |
LOW |
| DXCM |
Guide |
Non-GAAP operating-margin guidance |
BETTER |
guide ~23.75% vs. cons 23.5% (FY2026) |
MEDIUM |
| DXCM |
Return |
Day-1 residual (stock − beta × S&P 500) |
+5.2% |
— |
MEDIUM |
| DXCM |
Return |
5-day cumulative residual |
+6.4% (FOLLOW-THROUGH) |
A FY2026 revenue guide of ~$5.24B versus $5.22B consensus, following predicted Q2 revenue of ~$1.310B versus $1.290B consensus, leaves the implied second-half outlook modestly above Street rather than embedding a cut; higher gross- and operating-margin guidance should also drive positive EPS revisions after the initial move. |
MEDIUM |